AGAPE ATP CORP (ATPC)
US0083891087 - Common Stock
We assign a fundamental rating of 2 out of 10 to ATPC. ATPC was compared to 109 industry peers in the Health Care Providers & Services industry. The financial health of ATPC is average, but there are quite some concerns on its profitability. ATPC is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ATPC has reported negative net income.
In the past year ATPC has reported a negative cash flow from operations.
In the past 5 years ATPC reported 4 times negative net income.
In the past 5 years ATPC always reported negative operating cash flow.
1.2 Ratios
ATPC has a worse Return On Assets (-66.52%) than 88.89% of its industry peers.
Looking at the Return On Equity, with a value of -95.96%, ATPC is doing worse than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -66.52% | ||
| ROE | -95.96% | ||
| ROIC | N/A |
ROA(3y)-50.18%
ROA(5y)-31.34%
ROE(3y)-77.99%
ROE(5y)-47.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 61.64%, ATPC belongs to the best of the industry, outperforming 86.11% of the companies in the same industry.
ATPC's Gross Margin has improved in the last couple of years.
ATPC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.55%
GM growth 5Y45.02%
2. Health
2.1 Basic Checks
ATPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATPC has been reduced compared to 1 year ago.
Compared to 5 years ago, ATPC has less shares outstanding
Compared to 1 year ago, ATPC has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -1.93, we must say that ATPC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.93, ATPC is doing worse than 84.26% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that ATPC is not too dependend on debt financing.
The Debt to Equity ratio of ATPC (0.05) is better than 78.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.93 |
ROIC/WACCN/A
WACC9.17%
2.3 Liquidity
ATPC has a Current Ratio of 3.59. This indicates that ATPC is financially healthy and has no problem in meeting its short term obligations.
ATPC has a Current ratio of 3.59. This is amongst the best in the industry. ATPC outperforms 90.74% of its industry peers.
A Quick Ratio of 3.53 indicates that ATPC has no problem at all paying its short term obligations.
The Quick ratio of ATPC (3.53) is better than 90.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.59 | ||
| Quick Ratio | 3.53 |
3. Growth
3.1 Past
The earnings per share for ATPC have decreased strongly by -3320.90% in the last year.
Looking at the last year, ATPC shows a decrease in Revenue. The Revenue has decreased by -5.31% in the last year.
ATPC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.91% yearly.
EPS 1Y (TTM)-3320.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.31%
Revenue growth 3Y-25.42%
Revenue growth 5Y23.91%
Sales Q2Q%-7.97%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ATPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ATPC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AGAPE ATP CORP
NASDAQ:ATPC (12/20/2024, 8:00:01 PM)
After market: 1.51 +0.06 (+4.14%)1.45
+0.26 (+21.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.17%
Inst Owner ChangeN/A
Ins Owners25.47%
Ins Owner ChangeN/A
Market Cap5.79M
AnalystsN/A
Price TargetN/A
Short Float %5.05%
Short Ratio1.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.27 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.11 | ||
| P/tB | 2.12 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.8
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS0.34
BVpS0.69
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -66.52% | ||
| ROE | -95.96% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.64% | ||
| FCFM | N/A |
ROA(3y)-50.18%
ROA(5y)-31.34%
ROE(3y)-77.99%
ROE(5y)-47.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.55%
GM growth 5Y45.02%
F-Score3
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 146.82% | ||
| Cap/Sales | 6.72% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.59 | ||
| Quick Ratio | 3.53 | ||
| Altman-Z | -1.93 |
F-Score3
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)37.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3320.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.31%
Revenue growth 3Y-25.42%
Revenue growth 5Y23.91%
Sales Q2Q%-7.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-199.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-193.59%
OCF growth 3YN/A
OCF growth 5YN/A